-
Dapagliflozin, sold
under the
brand names Farxiga (US) and
Forxiga (EU)
among others, is a
medication used to
treat type 2 diabetes. It is also used to...
-
Dapagliflozin/sitagliptin, sold
under the
brand name Sidapvia, is a fixed-dose
combination anti-diabetic
medication used for the
treatment of type 2 diabetes...
-
Dapagliflozin/metformin, sold
under the
brand name
Xigduo Xr
among others, is a fixed-dose
combination anti-diabetic
medication used as an
adjunct to...
- they be
stopped temporarily before scheduled surgery. Canagliflozin,
dapagliflozin, and
empagliflozin should each be
stopped at
least three days before...
-
Dapagliflozin/saxagliptin/metformin, sold
under the
brand name
Qternmet XR
among others, is a fixed-dose
combination anti-diabetic
medication used as...
-
Dapagliflozin/saxagliptin, sold
under the
brand name Qtern, is a fixed-dose
combination anti-diabetic
medication used as an
adjunct to diet and exercise...
-
alogliptin A10BD14
Metformin and
repaglinide A10BD15
Metformin and
dapagliflozin A10BD16
Metformin and
canagliflozin A10BD17
Metformin and
acarbose A10BD18...
- the type 2
diabetes medicines canagliflozin (Invokana, Invokamet) and
dapagliflozin (Farxiga,
Xigduo XR). A 29 June 2016,
report on the
ongoing cardiovascular...
-
accepted by the Food and Drug
Administration (FDA) in the
United States;
dapagliflozin,
canagliflozin and empagliflozin.
Canagliflozin was the
first SGLT-2...
- anti-diabetics was
approved in 2019,
consisting of metformin, saxagliptin, and
dapagliflozin.
Another triple combination approval for metformin, linagliptin, and...
